venous insufficiency/pinheiro

O link é salvo na área de transferência

ArtigosTestes clínicosPatentes

Escolha o tipo de classificação

12 resultados

PYCNOGENOL in chronic venous insufficiency.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

The aim of out study was to investigate the efficacy of Pycnogenol - a French maritime pine bark extract - in the treatment of chronic venous insufficiency (CVI). The study consisted of a double-blind phase - in which 20 patients were recruited and randomly treated with placebo or Pycnogenol (100 mg

Pycnogenol in chronic venous insufficiency.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

Forty patients with chronic venous insufficiency (CVI) and varices of the legs were selected and double-blindly randomly assigned to a treatment with Pycnogenol (French maritime pine bark extract), 100 mg x 3/day or a placebo for 2 months, according to a double-blind experimental design. The effects

Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol: a prospective, controlled study.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

The aim of this study was to evaluate the clinical efficacy of standardized French maritime pine bark extract Pycnogenol in patients with severe chronic venous insufficiency (CVI). 98 subjects with symptomatic CVI and edema were randomly assigned to one group treated with 150 mg Pycnogenol a day

A Clinical Comparison of Pycnogenol, Antistax, and Stocking in Chronic Venous Insufficiency.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

This 8-week registry study was a comparative evaluation of Pycnogenol (French Maritime Pine Bark extract; Horphag Research, Geneva) and Antistax (grape leaf extract [GLE, Boehringer Ingelheim, Germany]) in controlling symptoms of chronic venous insufficiency (CVI). "Standard management" for CVI is

Chronic venous insufficiency and venous microangiopathy: management with compression and Pycnogenol®.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

The aim of this prospective supplement summer registry study was to evaluate the efficacy of Pycnogenol® in controlling symptoms of chronic venous insufficiency (CVI) and microcirculatory parameters: venous hypertension and microangiopathy. Pycnogenol® (Horphag Research) is the

Comparative study of Venostasin and Pycnogenol in chronic venous insufficiency.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

The aim of this study was to compare the efficacy of Venostasin (horse chestnut seed extract) and Pycnogenol (French maritime pine bark extract) in the treatment of chronic venous insufficiency (CVI). In an open, controlled comparative study 40 patients with diagnosed CVI were treated either with

Pycnogenol® in chronic venous insufficiency and related venous disorders.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

The present review provides an update of the biological profile of Pycnogenol in the light of its use in the treatment of chronic venous insufficiency (CVI) and related venous disorders such as deep vein thrombosis (DVT), post-thrombotic syndrome, long haul air-travel-related leg oedema, venous

Phlebotonics for venous insufficiency.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND Chronic venous insufficiency (CVI) is a common condition caused by inadequate blood flow through the veins, usually in the lower limbs. It can result in considerable discomfort with symptoms such as pain, itchiness and tiredness in the legs. Sufferers may also experience swelling and

Phlebotonics for venous insufficiency.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND Chronic venous insufficiency (CVI) is a common condition caused by valvular dysfunction with or without associated obstruction, usually in the lower limbs. It might result in considerable discomfort with symptoms such as pain, itchiness and tiredness in the legs. Patients with CVI may

Pycnogenol® (extract of French maritime pine bark) for the treatment of chronic disorders.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

BACKGROUND Oxidative stress has been implicated in the development of a number of conditions including cancer, arthritic disorders and cardiovascular disease. Pycnogenol(®), a herbal dietary supplement derived from French maritime pine bark extract, is standardised to contain 70% procyanidin which

Pycnogenol(®) for the treatment of chronic disorders.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology.

Apenas usuários registrados podem traduzir artigos

Entrar Inscrever-se

OBJECTIVE An increasing body of evidence indicates that Pycnogenol (PYC), a standardized extract of French maritime pine bark, has favorable pharmacological properties. This is a review of studies with both PYC and components of the preparation, that have helped to elucidate target sites and

Junte-se à nossa
página do facebook

Herbal & Natural Medicine

O mais completo banco de dados de ervas medicinais apoiado pela ciência

Funciona em 55 idiomas
Curas herbais apoiadas pela ciência
Reconhecimento de ervas por imagem
Mapa GPS interativo - marcar ervas no local (em breve)
Leia publicações científicas relacionadas à sua pesquisa
Pesquise ervas medicinais por seus efeitos
Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes

Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas